Online prescription care and subscriptions

AgelessRx review

I would evaluate AgelessRx for a defined treatment and an understandable continuing-care agreement. Its broader menu is useful for finding questions, but it does not establish a combined healthspan benefit. Separate the GLP-1 four-month starting offer from the NAD+ and sermorelin first-month promotions before comparing cost.

A useful next step?

Consider the purpose, the care relationship and the full commitment.

Visit AgelessRxOfficial provider website. No affiliate relationship is currently listed.

A reason to consider it

A reader who keeps product evidence, paid terms and clinical responsibility separate.

  • Distinct treatment pages expose different plan conditions.
  • Ongoing clinical messaging is described publicly.
  • General terms identify the platform and clinical parties.

What deserves scrutiny

A buyer seeking a proven all-purpose longevity prescription bundle.

  • Different starting prices describe different paid arrangements.
  • Menu breadth does not establish a combined healthspan effect.
  • The complete selected bill and refund boundary need clarification.
In this review

Three prices describe three different decisions

AgelessRx’s GLP-1 category starts at $139 per month for a four-month plan. Its NAD+ injection page instead lists $79 for the first month of a three-month plan billed in full, with $149 per month afterward. Sermorelin injection uses a $99 first-month offer under the same stated three-month condition and follow-on rate. [1] [4] [5]

I would keep those offers on separate lines. They do not establish a package price, equivalent supply or a complete first payment for each product. The attractive introductory number should not become the recurring budget simply because the menu places the treatments together.

The route and intended outcome come first

The NAD+ and sermorelin pages describe prescription injections. The general GLP-1 page promotes both full-dose and microdosing care. These are distinct preparations and clinical questions, not interchangeable ways to buy a general improvement in aging. [1] [4] [5]

I would identify the intended outcome and the evidence relevant to that particular product before deciding whether convenience justifies the service cost. An injection, a biomarker change and a longer healthy lifespan are different claims. One cannot fill the evidentiary gap for another.

Research activity does not settle the customer outcome

AgelessRx discusses its research programme and presents self-reported customer results on its treatment pages. Those are different kinds of information. The existence of a research project is not a completed demonstration that the marketed combination extends healthspan. [1] [4] [5]

The customer surveys also concern selected respondents, not randomized comparisons of the proposed care against another service. I would value a clear research question without converting the sales page’s result percentages into a personal forecast or an independently verified advantage.

The care relationship deserves its own check

The public pages describe clinician assessment, continuing provider messaging and prescription delivery if approved. The terms distinguish AgelessRx’s technology platform from the medical groups, individual providers and pharmacies responsible for care. State and product restrictions can apply. [1] [3]

Before paying, identify who will handle the specific treatment and how it connects with existing care. The prescription pages say compounded products have not been FDA reviewed or approved for safety, efficacy or quality. A wide menu does not remove that product-specific distinction. [1] [4] [5]

Subscription convenience includes a processing deadline

The general cancellation FAQ requires 48 hours’ notice before the next order; the terms frame the deadline around the applicable monthly processing date. For a longer paid term, I would confirm the actual date and treatment of a previously paid or processed order. Cancel-anytime wording alone does not establish that money comes back. [2] [3]

The shipping answer says approved treatment ships within five to seven business days. It does not guarantee arrival in that period. I would keep supply continuity, selected charges and any required follow-up in the cost comparison rather than using an introductory monthly number as the whole agreement. [2]

My decision stays with the defined need

AgelessRx can be a useful comparison for a particular online prescription pathway. I would not choose a broader collection of treatments because it is presented under a longevity brand. The care question and the financial agreement should each be understandable on their own.

Compare the relevant preparation with another provider, keeping the same supplied amount and paid term visible. Continue ordinary preventive care and measurement separately. A service can be convenient without having established the broader healthspan benefit implied by its catalogue.

Understanding the cost

GLP-1 $139/month starting rate requires four-month plan. NAD+ injection $79 first month and sermorelin injection $99 first month each require three-month plans billed in full, with $149/month afterward. These are separate products; exact first charges and complete selected agreements remain unverified. The products are separate purchases, not a quoted bundle. [1] [4] [5]

Build your cost estimate

Sources

  1. AgelessRx current GLP-1 service and four-month starting-price qualification
  2. AgelessRx general FAQ: cancellation and shipping
  3. AgelessRx terms, updated October 12, 2026: clinical parties, subscriptions, availability and charges
  4. AgelessRx NAD+ injection: introductory three-month-plan pricing
  5. AgelessRx sermorelin injection: introductory three-month-plan pricing

This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.

Affiliate partner

Before you go

Explore this option
Continue to your original choiceWe may earn a commission if you choose our partner. These services may differ in products, fees and clinical access.